TScan Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
TScan Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • TScan Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $1.25M, a 16.3% decline year-over-year.
  • TScan Therapeutics, Inc. annual Depreciation for 2023 was $5.36M, a 4.36% increase from 2022.
  • TScan Therapeutics, Inc. annual Depreciation for 2022 was $5.14M, a 54.4% increase from 2021.
  • TScan Therapeutics, Inc. annual Depreciation for 2021 was $3.33M, a 171% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.36M +$224K +4.36% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $5.14M +$1.81M +54.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $3.33M +$2.1M +171% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $1.23M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.